Exosens stock
EXENS.PAPARIndustrialsISIN FR001400Q9V2
57Score 57 out of 100, Neutral
Price and trend
34 / 100
Price history
+14% in one yearThe chart shows daily closes over 2 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 13% below it.
Since October 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Normal: the price is neither overheated nor sold off (RSI 35).
The price is 28% below its 52-week high. Largest decline in 2 years: 29% (March 2026 to November 2026).
Chart figures for advanced users
- SMA 50$63.49
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$66.76
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)35
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDbelow the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$45.43
- The lowest closing price of the last twelve months.
- Resistance$80.78
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Exosens belongs to the Aerospace & Defense industry (France) and, with a market value of $2.95B, is number 80 of 114 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $518.81M (up 18.8% year on year) and earnings of $47.32M (up 39.1%).
- For fiscal 2026, analysts expect on average revenue of $627M (up 20.9%) and adjusted earnings per share of $2.08 (up 56.4%).
Show more
- MEQIRI Score 57 out of 100 (Neutral): rank 634 of 1018 in Industrials, median 61.
- The P/E is 46.3 (Aerospace & Defense median 31.3, own median of recent years 45).
- Our model puts fair value at $61.11, with the price 5% below it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Growing faster than its industryRevenue up 25.6% a year since 2020, Aerospace & Defense median 10.6%.Growth 76
- Analysts expect strong earnings growthUp 24.4% a year through 2028 (estimates from 9 analysts).Growth 76
Weaknesses
- DilutionShare count up 68% since 2020.Capital allocation 37
- Volatile share priceVolatility 46% a year over the last 12 months.
Its standout strengths are growth and fundamentals, while capital allocation and technical analysis hold the score back.
Daily figure as of 13 Nov 2026
How the score is calculatedScore overview
Fundamentals are strong, with strong cash generation.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk high
How well MEQIRI warnsOne of the 30% with the highest crash risk among smaller stocks.
From 2016 to 2025, 36 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.
Valuation
Valuation signal
Fairly valuedIn our model the price counts as cheap below $43.65 and expensive above $101.86 (uncertainty high, based on the price swings of the past year).
The two parts of the fair value come to $83.02 (cash-flow model) and $39.21 (industry comparison), and the gap between them shows how uncertain the estimate is.
Calculated with a cost of equity of 7.8%. At 8.8% the fair value would be $54.00, at 6.8% it would be $71.81.
Valuation metrics
Half from the cash-flow model, half from earnings times the industry P/E (31.3).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Jun 2026, revenue rose 15.1% on the twelve months before. Revenue has grown strongly since 2020, at around 26% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 22%, operating 22%, net not measured.
Debt & balance sheet
latest quarterModerate debt, and interest is adequately covered.
Earnings
- Next earnings
- No date announced.
- Last reported
- 28 Jul 2026EPS reported $0.33
Analyst estimates
Earnings estimates have barely changed since 15 Oct 2026.
- Earnings per share
- $2.08−0.2%
- Revenue
- $627M+0.1%
- Earnings per share
- $2.69+0.2%
- Revenue
- $713.65M+0.2%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
What happened at Exosens
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
1018 rated companies in Industrials
- This company
- 57
- Sector median
- 61
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Aerospace & Defense
The next larger and next smaller companies by market value
- Firefly AerospaceFLY $4.35B41
- RENK GroupR3NK.DE $3.64B56
- LisiFII.PA $3.39B64
- Archer AviationACHR $3.39B33
- Intuitive MachinesLUNR $2.64B40
- AstronicsATRO $2.6B60
- V2XVVX $2.54B63
- Exail TechnologiesEXA.PA $2.36B45
ETFs that hold Exosens
Held by 14 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| VanEck Defense UCITS ETFDFEN | 0.64% | 0.55% | €5.8B |
| Amundi MSCI EMU Small Cap ESG Broad Transition UCITS ETF DISTLGWU | 0.56% | 0.40% | €580.62M |
| UBS MSCI EMU Small Cap UCITS ETF EUR disUEFD | 0.35% | 0.28% | €630.46M |
Show 5 more
| Amundi MSCI Europe Small Cap ESG Broad Transition UCITS ETF DistX026 | 0.22% | 0.23% | €321.86M |
| Xtrackers MSCI Europe Small Cap UCITS ETF 1CXXSC | 0.13% | 0.30% | €3.45B |
| iShares MSCI World Small Cap CTB Enhanced ESG UCITS ETFCBUG | 0.10% | 0.10% | €395.74M |
| Amundi MSCI Smart Cities UCITS ETF ACCAMEC | 0.09% | 0.45% | €62.23M |
| UBS MSCI EMU Select Factor Mix UCITS ETF EUR accUIQN | 0.06% | 0.34% | €16.96M |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 30 May 2025)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.